← SynDRA
ADOMEGLIVANT
SynDRA canonical compound SYN0038497 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | GCGR |
|---|
| Mechanism of action | glucagon receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- GCGR ANTAGONIST
- Glucagon receptor antagonist
- GLRA2 ANTAGONIST
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Adomeglivant, (-)-
- LY2409021
- LY-2409021
- Oral glucagon receptor antagonist (type 2 diabetes), Eli Lilly
- LY 2409021
- adomeglivantum
- (-)-adomeglivant
- RefChem:109813
- Adomeglivant [USAN]
- UNII-74Z5ZL2KVG
- Adomeglivant (USAN)
- ADOMEGLIVANT [INN]
- ADOMEGLIVANT [WHO-DD]
- GTPL9479
- orb1707712
- SCHEMBL29379087
- C32H36F3NO4
- FASLTMSUPQDLIB-MHZLTWQESA-N
- BDBM50611796
- EX-A12383
- MFCD30343860
- AKOS040741049
- CS-5729
- NCGC00510498-02
- DA-50239
- HY-19904
- MS-30128
- NS00073385
- D10861
- F85410
- T14130
Look up ADOMEGLIVANT in the interactive SynDRA portal →